Literature DB >> 15292278

Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.

Alexander Kiani1, Ivonne Habermann, Michael Haase, Silvia Feldmann, Sabine Boxberger, Maria A Sanchez-Fernandez, Christian Thiede, Martin Bornhäuser, Gerhard Ehninger.   

Abstract

The calcineurin-dependent, cyclosporin A (CsA)-sensitive transcription factor nuclear factor of activated T cells (NFAT) represents a group of proteins, which is well-characterized as a central regulatory element of cytokine expression in activated T cells. In contrast, little is known about the expression or function of NFAT family members in myeloid cells; moreover, it is unclear whether they are expressed by hematopoietic stem/progenitor cells. Here, we show that NFATc2 (NFAT1) is expressed at high levels in CD34+ cells and megakaryocytes but not in cells committed to the neutrophilic, monocytic, or erythroid lineages. Cytokine-induced in vitro differentiation of CD34+ cells into neutrophil granulocytes results in the rapid suppression of NFATc2 RNA and protein. NFATc2 dephosphorylation/rephosphorylation as well as nuclear/cytoplasmic translocation in CD34+ cells follow the same calcineurin-dependent pattern as in T lymphocytes, suggesting that NFATc2 activation in these cells is equally sensitive to inhibition with CsA. Finally, in vitro proliferation, but not differentiation, of CD34+ cells cultured in the presence of fms-like tyrosine kinase 3 ligand (FLT3L), stem cell factor, granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-3, and G-CSF is profoundly inhibited by treatment with CsA in a dose-dependent manner. These results suggest a novel and unexpected role for members of the NFAT transcription factor family in the hematopoietic system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292278     DOI: 10.1189/jlb.0404259

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  20 in total

1.  Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development.

Authors:  Martin R Müller; Yoshiteru Sasaki; Irena Stevanovic; Edward D Lamperti; Srimoyee Ghosh; Sonia Sharma; Curtis Gelinas; Derrick J Rossi; Matthew E Pipkin; Klaus Rajewsky; Patrick G Hogan; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-07       Impact factor: 11.205

2.  Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2.

Authors:  Wolfgang Bauer; Martina Rauner; Michael Haase; Satu Kujawski; Laleh S Arabanian; Ivonne Habermann; Lorenz C Hofbauer; Gerhard Ehninger; Alexander Kiani
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

3.  NFATc1 as a therapeutic target in FLT3-ITD-positive AML.

Authors:  S K Metzelder; C Michel; M von Bonin; M Rehberger; E Hessmann; S Inselmann; M Solovey; Y Wang; K Sohlbach; C Brendel; T Stiewe; J Charles; A Ten Haaf; V Ellenrieder; A Neubauer; S Gattenlöhner; M Bornhäuser; A Burchert
Journal:  Leukemia       Date:  2015-04-14       Impact factor: 11.528

4.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

5.  C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.

Authors:  John A Pulikkan; Philomina S Peramangalam; Viola Dengler; Phoenix A Ho; Claude Preudhomme; Soheil Meshinchi; Maximilian Christopeit; Oliver Nibourel; Carsten Müller-Tidow; Stefan K Bohlander; Daniel G Tenen; Gerhard Behre
Journal:  Blood       Date:  2010-10-01       Impact factor: 22.113

6.  Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.

Authors:  Sébastien Malinge; Meghan Bliss-Moreau; Gina Kirsammer; Lauren Diebold; Timothy Chlon; Sandeep Gurbuxani; John D Crispino
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

7.  Early growth response-1 (EGR-1) and nuclear factor of activated T cells (NFAT) cooperate to mediate CD40L expression in megakaryocytes and platelets.

Authors:  Scott A Crist; Bennett D Elzey; Michelle T Ahmann; Timothy L Ratliff
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

8.  Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.

Authors:  Scott A Crist; Daniel L Sprague; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-07       Impact factor: 22.113

Review 9.  Serine/threonine phosphatases in osteoclastogenesis and bone resorption.

Authors:  Ismael Y Karkache; Jeyaram R Damodaran; David H H Molstad; Elizabeth W Bradley
Journal:  Gene       Date:  2020-12-16       Impact factor: 3.688

10.  Calcineurin/NFAT signalling inhibits myeloid haematopoiesis.

Authors:  Jan Fric; Clarice X F Lim; Esther G L Koh; Benjamin Hofmann; Jinmiao Chen; Hock Soon Tay; Siti Aminah Bte Mohammad Isa; Alessandra Mortellaro; Christiane Ruedl; Paola Ricciardi-Castagnoli
Journal:  EMBO Mol Med       Date:  2012-02-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.